Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Andersen

Showing results (21-30 of 241) with videos related to

Pageof 25
Sort By:
Plos One|June 12, 2013
Credibility analysis of putative disease-causing genes using bioinformaticsOlubunmi Abel, John F Powell, Peter M Andersen, et al.
Annals of Neurology|July 18, 2018
Neurofilament light: A candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversionMichael Benatar, Joanne Wuu, Peter M Andersen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 10, 2016
Comment on "Cutting Edge: Inhibiting TBK1 by Compound II Ameliorates Autoimmune Disease in Mice"David Brenner, Peter M Andersen, Albert C Ludolph, et al.
Investigative Ophthalmology & Visual Science|March 5, 2011
Different impact of ALS on laminin isoforms in human extraocular muscles versus limb musclesJing-Xia Liu, Thomas Brännström, Peter M Andersen, et al.
Plos One|March 8, 2013
Distinct changes in synaptic protein composition at neuromuscular junctions of extraocular muscles versus limb muscles of ALS donorsJing-Xia Liu, Thomas Brännström, Peter M Andersen, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 19, 2012
Pyrimethamine decreases levels of SOD1 in leukocytes and cerebrospinal fluid of ALS patients: a phase I pilot studyDale J Lange, Peter M Andersen, Rahul Remanan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2005
Systematically perturbed folding patterns of amyotrophic lateral sclerosis (ALS)-associated SOD1 mutantsMikael J Lindberg, Roberth Byström, Niklas Boknäs, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 24, 2010
The human G93A SOD1 phenotype closely resembles sporadic amyotrophic lateral sclerosisMatthis Synofzik, Rubén Fernández-Santiago, Walter Maetzler, et al.
Molecular Genetics and Metabolism|January 24, 2012
ALS patients with mutations in the SOD1 gene have an unique metabolomic profile in the cerebrospinal fluid compared with ALS patients without mutationsAnna Wuolikainen, Peter M Andersen, Thomas Moritz, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 9, 2012
pNfH is a promising biomarker for ALSJeban Ganesalingam, Jiyan An, Robert Bowser, et al.
Pageof 25

Showing results (21-30 of 241) with videos related to

Sort By:
Pageof 25
Plos One|June 12, 2013
Credibility analysis of putative disease-causing genes using bioinformaticsOlubunmi Abel, John F Powell, Peter M Andersen, et al.
Annals of Neurology|July 18, 2018
Neurofilament light: A candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversionMichael Benatar, Joanne Wuu, Peter M Andersen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 10, 2016
Comment on "Cutting Edge: Inhibiting TBK1 by Compound II Ameliorates Autoimmune Disease in Mice"David Brenner, Peter M Andersen, Albert C Ludolph, et al.
Investigative Ophthalmology & Visual Science|March 5, 2011
Different impact of ALS on laminin isoforms in human extraocular muscles versus limb musclesJing-Xia Liu, Thomas Brännström, Peter M Andersen, et al.
Plos One|March 8, 2013
Distinct changes in synaptic protein composition at neuromuscular junctions of extraocular muscles versus limb muscles of ALS donorsJing-Xia Liu, Thomas Brännström, Peter M Andersen, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|September 19, 2012
Pyrimethamine decreases levels of SOD1 in leukocytes and cerebrospinal fluid of ALS patients: a phase I pilot studyDale J Lange, Peter M Andersen, Rahul Remanan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2005
Systematically perturbed folding patterns of amyotrophic lateral sclerosis (ALS)-associated SOD1 mutantsMikael J Lindberg, Roberth Byström, Niklas Boknäs, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 24, 2010
The human G93A SOD1 phenotype closely resembles sporadic amyotrophic lateral sclerosisMatthis Synofzik, Rubén Fernández-Santiago, Walter Maetzler, et al.
Molecular Genetics and Metabolism|January 24, 2012
ALS patients with mutations in the SOD1 gene have an unique metabolomic profile in the cerebrospinal fluid compared with ALS patients without mutationsAnna Wuolikainen, Peter M Andersen, Thomas Moritz, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 9, 2012
pNfH is a promising biomarker for ALSJeban Ganesalingam, Jiyan An, Robert Bowser, et al.
Pageof 25